---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-032491"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-08T00:36:26.077768+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics establishes $50M ATM equity sales program

## Summary
- Entered into at-market issuance agreement with Oppenheimer, B. Riley, and JonesTrading on Nov 17, 2023.
- May offer and sell up to $50,000,000 of common stock from time to time at the market.
- Agents receive 3.0% commission on gross proceeds from sales effectuated through them.
- Program is under a new S-3 registration statement (File No. 333-275638) filed with the SEC.

## SEC filing metadata
- accession: 0001437749-23-032491
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/0001437749-23-032491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/isr20231117_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-032491
- JSON: https://secwatch.observer/filing/0001437749-23-032491.json
- Plain text: https://secwatch.observer/filing/0001437749-23-032491.txt

## Key facts
- Material Agreements
  Perspective Therapeutics, Inc. entered into At Market Issuance Sales Agreement with Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC valued at $50,000,000 (effective 2023-11-17).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC
  - Value: $50,000,000
  - Effective: 2023-11-17
  source text: On November 17, 2023, Perspective Therapeutics, Inc. (the “Company”) entered into an At Market Issuance Sales Agreement (the “Agreement”) with Oppenheimer & Co. Inc., B. Riley Securities, Inc. and JonesTrading Institutional Services LLC (each, an “Agent” and together, the “Agents”) to create an “at-the-market” equity program under which the Company from time to time may offer and sell shares (the “ATM Shares”) of its common stock, par value $0.001 per share (“Company Common Stock”), through or to the Agents.
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000143774923032491/0001437749-23-032491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.